Benzinga · Mar 19, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday.
The Dow traded up 0.63% to 39,034.59 while the NASDAQ rose 0.35% to 16,160.20. The S&P 500 also rose, gaining, 0.41% to 5,170.36.
Check This Out: Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Leading and Lagging Sectors
Energy shares rose by 1% on Tuesday.
In trading on Tuesday, communication services shares fell by 0.2%.
Top Headline
Caleres Inc (NYSE: CAL) reported upbeat fourth-quarter results.
Caleres reported fourth-quarter FY23 sales growth of 0.1% year-on-year to $697.12 million, beating the analyst consensus estimate of $694.33 million. Adjusted EPS of 86 cents beat the analyst consensus of 85 cents.
Caleres expects first-quarter FY24 net sales to be flat to +1%. EPS to be in line with the fourth quarter of 2023 on an adjusted basis.
Equities Trading UP
Ontrak, Inc. (NASDAQ: OTRK) shares shot up 93% to $0.3675 ahead of the company's presentation at the 36th Annual Roth Conference.
Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) got a boost, surging ...
Benzinga · Mar 19, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.
The Dow traded up 0.54% to 39,001.22 while the NASDAQ fell 0.34% to 16,048.51. The S&P 500 also rose, gaining, 0.02% to 5,150.45.
Check This Out: Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Leading and Lagging Sectors
Energy shares rose by 0.7% on Tuesday.
In trading on Tuesday, communication services shares fell by 1%.
Top Headline
Shares of Core & Main, Inc. (NYSE: CNM) gained around 7% on Tuesday after the company reported fourth-quarter results.
Core & Main posted quarterly earnings of 34 cents per share, missing analysts’ estimates of 35 cents per share. The company’s quarterly sales came in at $1.44 billion, versus expectations of $1.43 billion.
Core & Main said it expects 2024 net sales of $7.4 billion to $7.6 billion and adjusted EBITDA of $925 million to $975 million.
Equities Trading UP
Ontrak, Inc. (NASDAQ: OTRK) shares shot up 132% to $0.44 ahead of the company's presentation at the 36th Annual Roth Conference.
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:
Benzinga · Mar 19, 2024
U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.11% to 38,831.86 while the NASDAQ fell 0.63% to 16,001.30. The S&P 500 also fell, dropping, 0.28% to 5,135.12.
Check This Out: Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Leading and Lagging Sectors
Energy shares rose by 0.4% on Tuesday.
In trading on Tuesday, information technology shares fell by 0.8%.
Top Headline
Housing starts in the U.S. surged 10.7% month-over-month to an annualized rate of 1.521 million in February following a 12.3% decline in January.
Equities Trading UP
Ontrak, Inc. (NASDAQ: OTRK) shares shot up 153% to $0.4787 ahead of the company's presentation at the 36th Annual Roth Conference.
Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) got a boost, surging 97% to $21.00 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21.
Enveric Biosciences, Inc (NASDAQ:
Benzinga · Nov 29, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday.
The Dow traded up 0.42% to 35,564.02 while the NASDAQ rose 0.17% to 14,305.43. The S&P 500 also rose, gaining, 0.26% to 4,566.65.
Check This Out: How To Earn $500 A Month From NVIDIA Stock After Last Week's Strong Earnings Report
Leading and Lagging Sectors
Real estate shares rose by 1.2% on Wednesday.
In trading on Wednesday, communication services shares fell by 0.8%.
Top Headline
Hormel Foods Corp (NYSE: HRL) reported weaker-than-expected earnings for its fourth quarter on Wednesday.
The company posted a fourth-quarter FY23 sales decline of 2.6% year-on-year to $3.198 billion, missing the analyst consensus estimate of $3.264 billion. Adjusted EPS of $0.42 missed the consensus estimate of $0.44.
Hormel sees FY24 sales of $12.2 billion - $12.5 billion versus the consensus of $12.28 billion. The company sees FY24 adjusted EPS of $1.51 - $1.65 against the Street view of $1.68.
Equities Trading UP
Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares shot up 301% to $17.66. Vivos Therapeutics received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances.
Shares of Rover Group, Inc. (NASDAQ: ROVR) got a boost, shooting 29% to $10.93 after the company announced it agreed to be acquired by Blackstone in a ...
